Stryker Orthopaedics and Spine — Net Sales increased by 0.1% to $2.25B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.7%, from $2.27B to $2.25B. Over 3 years (FY 2021 to FY 2024), Orthopaedics and Spine — Net Sales shows an upward trend with a 6.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong market demand and successful product adoption, while a decrease may signal competitive pressure or reduced procedure volumes.
This metric represents the total revenue generated from the sale of orthopaedic and spine-related medical devices, inclu...
Comparable to revenue reported by major medical device peers specializing in reconstructive implants and spinal hardware.
syk_segment_orthopaedics_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.94B | $1.81B | $2.06B | $1.85B | $1.94B | $1.89B | $2.15B | $2.09B | $2.14B | $2.05B | $2.39B | $2.24B | $2.31B | $2.27B | $2.26B | $2.36B | $2.25B | $2.25B |
| QoQ Change | — | -6.4% | +13.9% | -10.2% | +5.0% | -2.7% | +13.7% | -2.9% | +2.3% | -4.0% | +16.5% | -6.0% | +2.7% | -1.5% | -0.5% | +4.3% | -4.4% | +0.1% |
| YoY Change | — | — | — | — | +0.5% | +4.4% | +4.3% | +12.7% | +9.9% | +8.4% | +11.0% | +7.5% | +7.9% | +10.7% | -5.4% | +4.9% | -2.3% | -0.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.